The latest leukaemia news
FDA approves quizartinib for newly diagnosed acute myeloid leukaemia
On July 20, 2023, the Food and Drug Administration approved quizartinib with standard cytarabine and…
Browsing: Leukaemia
Survival of children with acute lymphatic leukaemia further increased
The five-year survival of all children with acute lymphatic leukaemia (ALL) has continued to increase…
Cell therapy shows promise for patients with relapsed leukaemia
A single infusion of chimeric antigen receptor T-cell (CAR-T) therapy induced complete response or remission…
New tool pinpoints gaps in awareness of blood cancer symptoms
A new tool could help identify gaps in the public’s knowledge of blood cancer symptoms…
Obesity and high weight linked to adverse outcomes in leukaemia treatment
As certain countries face a growing obesity epidemic, scientists are taking a closer look at…
Unlocking the mystery of long-lasting cancer treatment
In recent years, CAR T-cells – genetically engineered T-cells (a type of immune cell) designed…
Study demonstrates safety of microbiota transplant therapy in stem cell transplant and leukaemia patients
Published in the Journal of Clinical Oncology, University of Minnesota Medical School researchers led a study…
Leukaemia spread fueled by messenger particles
Messenger particles released by leukaemia cells use a chemical modification on their surface to navigate…
Further hope for base-edited T-cell therapy to treat resistant leukaemia
Three young patients with relapsed T-cell leukaemia have now been treated with base-edited T-cells, as…
Fixed-duration plus venetoclax may benefit patients with high-risk chronic lymphocytic leukaemia
First-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic…